The molecular mechanisms underlying these effects include the impact on the Wnt/β-catenin pathway and the cell cycle, confirmed by the inhibited expression of β-catenin, c-Myc, and cyclin D1 in RBMS3 expressing cancer cells [7,48]. Here, RBMS3 is linked to cancer.